Overview

Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of morning versus evening intake of Simvastatin Controlled Release tablet 20mg for 8 weeks in patients with hyperlipidemia. This study will investigate equivalence of the low-density lipoprotein(LDL) cholesterol percent change.

Phase:

Phase 3

Details

Lead Sponsor:

Hanmi Pharmaceutical Company Limited

Treatments:

Simvastatin